Literature DB >> 18090901

Nutrition and the prevention of cataracts.

Mark M Fernandez1, Natalie A Afshari.   

Abstract

PURPOSE OF REVIEW: Oxidative stress is a major cause of cataract development. Numerous studies have been published regarding the effects of nutritional supplementation on cataract progression. RECENT
FINDINGS: Basic science research has demonstrated a protective effect of antioxidants on lens tissue, and supplementation with vitamin C and lutein/zeaxanthin has been associated with a decreased risk of cataract formation in multiple observational studies. One large interventional trial demonstrated a significant difference in participants treated with high-dose vitamin C versus placebo, but a more recent interventional study did not replicate these findings. In a review of the carotenoids lutein and zeaxanthin, the Food and Drug Administration concluded there is insufficient evidence to suggest that supplementation with these carotenoids lowers the risk of cataract formation. While high doses of multivitamins, antioxidants, or lutein and zeaxanthin are unlikely to be of significant ophthalmic benefit to the general public, these nutrients may help individuals exposed to high oxidative stress, such as heavy smokers, and those with poor nutrition.
SUMMARY: Supplementation with vitamin C, lutein, zeaxanthin, or a multivitamin may help certain populations, but is unlikely to affect the progression of cataracts in most patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18090901     DOI: 10.1097/ICU.0b013e3282f2d7b6

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  12 in total

Review 1.  Antioxidants and vision health: facts and fiction.

Authors:  Ashok K Grover; Sue E Samson
Journal:  Mol Cell Biochem       Date:  2013-12-06       Impact factor: 3.396

2.  Investigation of dynamic thiol-disulphide homoeostasis in age-related cataract patients with a novel and automated assay.

Authors:  Haci Murat Sagdik; Fatma Ucar; Mehmet Tetikoglu; Serdar Aktas; Fatih Ozcura; Havva Kocak; Salim Neselioglu; Funda Eren
Journal:  Int Ophthalmol       Date:  2017-04-10       Impact factor: 2.031

3.  Effect of estrogen replacement therapy on lens epithelial cell apoptosis in an experimental rat model.

Authors:  Fatih Ozcura; Sema Oruç Dündar; Emel Dikicioğlu Cetin; Nahit Beder; Mehmet Dündar
Journal:  Int Ophthalmol       Date:  2009-12-05       Impact factor: 2.031

4.  Selenium and mercury in the Brazilian Amazon: opposing influences on age-related cataracts.

Authors:  Mélanie Lemire; Myriam Fillion; Benoît Frenette; Annie Mayer; Aline Philibert; Carlos José Sousa Passos; Jean Rémy Davée Guimarães; Fernando Júnior Barbosa; Donna Mergler
Journal:  Environ Health Perspect       Date:  2010-11       Impact factor: 9.031

5.  Connexin mediated cataract prevention in mice.

Authors:  Lin Li; Catherine Cheng; Chun-hong Xia; Thomas W White; Daniel A Fletcher; Xiaohua Gong
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

Review 6.  Antioxidant defenses in the ocular surface.

Authors:  Ying Chen; Gaurav Mehta; Vasilis Vasiliou
Journal:  Ocul Surf       Date:  2009-10       Impact factor: 5.033

Review 7.  Vitamin C: update on physiology and pharmacology.

Authors:  J Mandl; A Szarka; G Bánhegyi
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 8.  Injectable hydrogels for ophthalmic applications.

Authors:  Kai Wang; Zongchao Han
Journal:  J Control Release       Date:  2017-10-20       Impact factor: 9.776

9.  Serotonin levels in aqueous humor of patients with primary open-angle glaucoma.

Authors:  V Zanon-Moreno; P Melo; M M Mendes-Pinto; C J Alves; J J Garcia-Medina; I Vinuesa-Silva; M A Moreno-Nadal; M D Pinazo-Duran
Journal:  Mol Vis       Date:  2008-11-28       Impact factor: 2.367

10.  Flavonoid intake and the risk of age-related cataract in China's Heilongjiang Province.

Authors:  Yingna Ma; Weiqi Gao; Kun Wu; Yongping Bao
Journal:  Food Nutr Res       Date:  2015-12-11       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.